Ignite Creation Date:
2025-12-24 @ 2:42 PM
Ignite Modification Date:
2026-03-12 @ 2:31 AM
Study NCT ID:
NCT05567159
Status:
COMPLETED
Last Update Posted:
2024-10-04
First Post:
2022-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Donanemab (LY3002813) in Healthy Participants
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
18616
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None